These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22128892)

  • 21. Hypoxic enhancement of exosome release by breast cancer cells.
    King HW; Michael MZ; Gleadle JM
    BMC Cancer; 2012 Sep; 12():421. PubMed ID: 22998595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic Modification of Hypoxia.
    Horsman MR; Sørensen BS; Busk M; Siemann DW
    Clin Oncol (R Coll Radiol); 2021 Nov; 33(11):e492-e509. PubMed ID: 34535359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular and molecular background underlying the diversity in therapeutic responses between primary tumours and metastases.
    Romano S; D'Angelillo A; Romano A; Nappo G; Romano MF
    Curr Med Chem; 2014; 21(14):1631-8. PubMed ID: 23992331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours.
    Webster L; Hodgkiss RJ; Wilson GD
    Cytometry; 1995 Dec; 21(4):344-51. PubMed ID: 8608732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The comet assay in clinical practice.
    Olive PL; Durand RE; Jackson SM; Le Riche JC; Luo C; Ma R; McLaren DB; Aquino-Parsons C; Thomson TA; Trotter T
    Acta Oncol; 1999; 38(7):839-44. PubMed ID: 10606413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of monocarboxylate transporter densities during hypoxia in brain and breast tumour cells.
    Cheng C; Edin NF; Lauritzen KH; Aspmodal I; Christoffersen S; Jian L; Rasmussen LJ; Pettersen EO; Xiaoqun G; Bergersen LH
    Cell Oncol (Dordr); 2012 Jun; 35(3):217-27. PubMed ID: 22700320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring hypoxic biology to improve radiotherapy outcomes.
    Li C; Wiseman L; Okoh E; Lind M; Roy R; Beavis AW; Pires IM
    Expert Rev Mol Med; 2022 Apr; 24():e21. PubMed ID: 35586915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A hypoxic ticket to the bone metastatic niche.
    Vanharanta S
    Breast Cancer Res; 2015 Sep; 17(1):122. PubMed ID: 26337273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transiently hypoxic tumour cell turnover and radiation sensitivity in human tumour xenografts.
    Wadsworth BJ; Lee CM; Bennewith KL
    Br J Cancer; 2022 Jun; 126(11):1616-1626. PubMed ID: 35031765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation.
    Wadsworth BJ; Cederberg RA; Lee CM; Firmino NS; Franks SE; Pan J; Colpo N; Lin KS; Benard F; Bennewith KL
    Cancer Lett; 2020 Nov; 493():31-40. PubMed ID: 32763272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis and treatment of tumor metastases].
    Petruzelka L
    Vnitr Lek; 2001 Aug; 47(8):555-60. PubMed ID: 15633397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8.
    Rofstad EK; Halsør EF
    Br J Cancer; 2002 Jan; 86(2):301-8. PubMed ID: 11870523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CAIX furthers tumour progression in the hypoxic tumour microenvironment of esophageal carcinoma and is a possible therapeutic target.
    Drenckhan A; Freytag M; Supuran CT; Sauter G; Izbicki JR; Gros SJ
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1024-1033. PubMed ID: 29865880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxic pathobiology of breast cancer metastasis.
    Schito L; Rey S
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):239-245. PubMed ID: 28526262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxic sensitizer and cytotoxin for head and neck cancer.
    Lee DJ; Moini M; Giuliano J; Westra WH
    Ann Acad Med Singap; 1996 May; 25(3):397-404. PubMed ID: 8876907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review.
    Horsman MR
    Acta Oncol; 1995; 34(5):571-87. PubMed ID: 7546822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia stimulates CXCR4 signalling in ileal carcinoids.
    Arvidsson Y; Bergström A; Arvidsson L; Kristiansson E; Ahlman H; Nilsson O
    Endocr Relat Cancer; 2010 Jun; 17(2):303-16. PubMed ID: 20071457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic targeting of the hypoxic tumour microenvironment.
    Singleton DC; Macann A; Wilson WR
    Nat Rev Clin Oncol; 2021 Dec; 18(12):751-772. PubMed ID: 34326502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pH, hypoxia and metastasis.
    Hill RP; De Jaeger K; Jang A; Cairns R
    Novartis Found Symp; 2001; 240():154-65; discussion 165-8. PubMed ID: 11727927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer.
    Trinkaus ME; Hicks RJ; Young RJ; Peters LJ; Solomon B; Bressel M; Corry J; Fisher R; Binns D; McArthur GA; Rischin D
    J Med Imaging Radiat Oncol; 2014 Feb; 58(1):89-97. PubMed ID: 24529061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.